These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4135642)

  • 21. Proceedings: Abnormal factor 8 in Von Willebrand's disease.
    Thomson C; Forbes CD; Prentice CR
    Scott Med J; 1974 Jan; 19(1):58. PubMed ID: 4544862
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test.
    Brinkhous KM; Graham JE; Cooper HA; Allain JP; Wagner RH
    Thromb Res; 1975 Mar; 6(3):267-72. PubMed ID: 1078735
    [No Abstract]   [Full Text] [Related]  

  • 24. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
    Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Willebrand factor: immunological and biological study.
    Meyer D; Dreyfus MD; Larrieu MJ
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:66-71. PubMed ID: 4202741
    [No Abstract]   [Full Text] [Related]  

  • 26. [Von Willebrand's disease. Studies on platelet function, ristocetin induced platelet aggregation and factor VIII related antigen (author's transl)].
    Mimaya J; Nagao T; Iizuka A; Yamashita H
    Rinsho Ketsueki; 1975 Aug; 16(8):775-84. PubMed ID: 1081150
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The von Willebrand syndrome.
    Stableforth P; Hughes J; Wilson E; Dormandy KM
    Br J Haematol; 1975 Apr; 29(4):605-16. PubMed ID: 1081404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: Von Willebrand's disease in pregnancy.
    Leone G; Moneta E; Paparatti G; Boni P
    N Engl J Med; 1975 Aug; 293(9):456. PubMed ID: 1080256
    [No Abstract]   [Full Text] [Related]  

  • 30. Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families.
    Mahasandana C; Suvatte V; Püng-amritt P; Tuchinda S
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):243-7. PubMed ID: 316576
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Experimental model for von Willebrand's disease.
    Meyer D; Jenkins CS; Dreyfus M; Larrieu MJ
    Nature; 1973 Jun; 243(5405):293-4. PubMed ID: 4542702
    [No Abstract]   [Full Text] [Related]  

  • 32. Carrier of porcine von Willebrand's disease.
    Owen CA; Bowie EJ; Zollman PE; Fass DN; Gordon H
    Am J Vet Res; 1974 Feb; 35(2):245-8. PubMed ID: 4544307
    [No Abstract]   [Full Text] [Related]  

  • 33. Family studies of patients with reduced ristocetin aggregation and abnormalities of factor VIII and/or platelet function.
    Ekert H; Ananthakrishnan R; Muntz RH; Dowling S; D'Souza S
    Thromb Haemost; 1976 Aug; 36(1):78-85. PubMed ID: 1087478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter: 8-related antigen and von Willebrand factor.
    Firkin B; Koutts J
    Lancet; 1974 Apr; 1(7861):803-4. PubMed ID: 4132731
    [No Abstract]   [Full Text] [Related]  

  • 35. Von Willebrand's syndrome. Studies on a variant factor VIII.
    Hill FG; Chan MC; Hardisty RM
    Haemostasis; 1976; 5(5):276-84. PubMed ID: 797643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two genetic variants of von Willebrand's disease.
    Holmberg L; Nilsson IM
    N Engl J Med; 1973 Mar; 288(12):595-8. PubMed ID: 4539979
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: Enhanced factor VIII activity in von Willebrand's disease.
    Mannucci PM; Pareti FI; Ruggeri ZM
    N Engl J Med; 1974 May; 290(22):1259. PubMed ID: 4545219
    [No Abstract]   [Full Text] [Related]  

  • 38. von Willebrand's disease: current concepts.
    Green D; Chediak JR
    Am J Med; 1977 Mar; 62(3):315-8. PubMed ID: 300223
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Relation of von Willebrand factor to bleeding time.
    Weiss HJ
    N Engl J Med; 1974 Aug; 291(8):420. PubMed ID: 4546558
    [No Abstract]   [Full Text] [Related]  

  • 40. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
    Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
    Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.